• Info
  • Insider Ownership

Insider Trading & Ownership of Suzanne Ildstad

Location
Wellesley, MA
Summary
The estimated net worth of Suzanne Ildstad is at least $75.2M dollars as of 14 Jun 2023. Suzanne Ildstad is the Director of Talaris Therapeutics, Inc. and owns shares of Tourmaline Bio, Inc. (TRML) stock worth about $75.2M.
Signature
/s/ Mary Kay Fenton, attorney-in-fact
All Insider Reports
All Insider Reports

Notify me when Suzanne Ildstad files a new Insider Trading report.

⭐ Subscribe ⭐

Ownership of Suzanne Ildstad

Symbol Company Relationship Holdings Value Past Year Net Change Change % Report Period
TRML Tourmaline Bio, Inc. Director $75.2M 12 Jun 2023

Insider Transactions Reported by Suzanne Ildstad:

Sym Company Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.